{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:11:27Z","timestamp":1779927087943,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T00:00:00Z","timestamp":1320278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00277-011-1359-0","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T15:35:59Z","timestamp":1320248159000},"page":"679-685","source":"Crossref","is-referenced-by-count":40,"title":["Good adherence to imatinib therapy among patients with chronic myeloid leukemia\u2014a single-center observational study"],"prefix":"10.1007","volume":"91","author":[{"given":"Sofia","family":"J\u00f6nsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wadenvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,3]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","volume":"23","author":"A Hochhaus","year":"2009","unstructured":"Hochhaus A, O\u2019Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Muller MC, Radich JP, Rudoltz M, Mone M, Gathmann I, Hughes TP, Larson RA (2009) Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 23:1054\u20131061","journal-title":"Leukemia"},{"key":"1359_CR2","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F, Legros L, Charbonnier A, Guerci A, Varet B, Etienne G, Reiffers J, Rousselot P (2010) Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2\u00a0years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 11:1029\u20131035","journal-title":"Lancet Oncol"},{"key":"1359_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1345\/aph.1D207","volume":"38","author":"HH Tilson","year":"2004","unstructured":"Tilson HH (2004) Adherence or compliance? Changes in terminology. Ann Pharmacother 38:161\u2013162","journal-title":"Ann Pharmacother"},{"key":"1359_CR4","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003","unstructured":"World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva"},{"key":"1359_CR5","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","volume":"28","author":"D Marin","year":"2010","unstructured":"Marin D, Bazeos A, Mahon FX, Eliasson L, Milojkovic D, Bua M, Apperley JF, Szydlo R, Desai R, Kozlowski K, Paliompeis C, Latham V, Foroni L, Molimard M, Reid A, Rezvani K, de LH, Guallar C, Goldman J, Khorashad JS (2010) Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib. J Clin Oncol 28:2381\u20132388","journal-title":"J Clin Oncol"},{"key":"1359_CR6","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1182\/blood-2008-12-196543","volume":"113","author":"L Noens","year":"2009","unstructured":"Noens L, van Lierde MA, De BR, Verhoef G, Zachee P, Berneman Z, Martiat P, Mineur P, Van EK, MacDonald K, De GS, Albrecht T, Abraham I (2009) Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood 113:5401\u20135411","journal-title":"Blood"},{"key":"1359_CR7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.leukres.2010.10.017","volume":"35","author":"L Eliasson","year":"2011","unstructured":"Eliasson L, Clifford S, Barber N, Marin D (2011) Exploring chronic myeloid leukemia patients\u2019 reasons for not adhering to the oral anticancer drug imatinib as prescribed. Leuk Res 35:626\u2013630","journal-title":"Leuk Res"},{"key":"1359_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajh.22019","volume":"86","author":"P Ganesan","year":"2011","unstructured":"Ganesan P, Sagar TG, Dubashi B, Rajendranath R, Kannan K, Cyriac S, Nandennavar M (2011) Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia. Am J Hematol 86:471\u2013474","journal-title":"Am J Hematol"},{"key":"1359_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67\u201374","journal-title":"Med Care"},{"key":"1359_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0167-5273(94)02203-U","volume":"47","author":"KI Kjellgren","year":"1995","unstructured":"Kjellgren KI, Ahlner J, Saljo R (1995) Taking antihypertensive medication\u2014controlling or co-operating with patients? Int J Cardiol 47:257\u2013268","journal-title":"Int J Cardiol"},{"key":"1359_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00043798-199806000-00004","volume":"5","author":"KI Kjellgren","year":"1998","unstructured":"Kjellgren KI, Ahlner J, Dahlof B, Gill H, Hedner T, Saljo R (1998) Patients\u2019 and physicians\u2019 assessment of risks associated with hypertension and benefits from treatment. J Cardiovasc Risk 5:161\u2013166","journal-title":"J Cardiovasc Risk"},{"key":"1359_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2710.2006.00782.x","volume":"31","author":"B Sodergard","year":"2006","unstructured":"Sodergard B, Halvarsson M, Tully MP, Mindouri S, Nordstrom ML, Lindback S, Sonnerborg A, Lindblad AK (2006) Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 31:605\u2013616","journal-title":"J Clin Pharm Ther"},{"key":"1359_CR13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11096-006-9036-4","volume":"28","author":"B Sodergard","year":"2006","unstructured":"Sodergard B, Halvarsson M, Lindback S, Sonnerborg A, Tully MP, Lindblad AK (2006) Differences in adherence and motivation to HIV therapy\u2014two independent assessments in 1998 and 2002. Pharm World Sci 28:248\u2013256","journal-title":"Pharm World Sci"},{"key":"1359_CR14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","volume":"10","author":"DE Morisky","year":"2008","unstructured":"Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:348\u2013354","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1359_CR15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/bmj.314.7080.572","volume":"314","author":"JM Bland","year":"1997","unstructured":"Bland JM, Altman DG (1997) Cronbach\u2019s alpha. BMJ 314:572","journal-title":"BMJ"},{"key":"1359_CR16","unstructured":"Svenska KML-gruppen (2010) Nationella riktlinjer f\u00f6r diagnostik och behandling av kronisk myeloisk leukemi. www.sfhem.se"},{"key":"1359_CR17","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J, Cervantes F, Deininger M, Gratwohl A, Guilhot F, Hochhaus A, Horowitz M, Hughes T, Kantarjian H, Larson R, Radich J, Simonsson B, Silver RT, Goldman J, Hehlmann R (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041\u20136051","journal-title":"J Clin Oncol"},{"key":"1359_CR18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031\u20131037","journal-title":"N Engl J Med"},{"key":"1359_CR19","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van dVV, Bi W, Dee R, der SE Van, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe against cancer program. Leukemia 17:2474\u20132486","journal-title":"Leukemia"},{"key":"1359_CR20","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van dVV, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cave H, Pane F, Aerts JL, De MD, Thirion X, Pradel V, Gonzalez M, Viehmann S, Malec M, Saglio G, van Dongen JJ (2003) Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer program. Leukemia 17:2318\u20132357","journal-title":"Leukemia"},{"key":"1359_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.hco.0000166597.52335.23","volume":"20","author":"M Krousel-Wood","year":"2005","unstructured":"Krousel-Wood M, Hyre A, Muntner P, Morisky D (2005) Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol 20:296\u2013300","journal-title":"Curr Opin Cardiol"},{"key":"1359_CR22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1345\/aph.1E071","volume":"38","author":"SJ Shalansky","year":"2004","unstructured":"Shalansky SJ, Levy AR, Ignaszewski AP (2004) Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38:1363\u20131368","journal-title":"Ann Pharmacother"},{"key":"1359_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.hco.0000126978.03828.9e","volume":"19","author":"M Krousel-Wood","year":"2004","unstructured":"Krousel-Wood M, Thomas S, Muntner P, Morisky D (2004) Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19:357\u2013362","journal-title":"Curr Opin Cardiol"},{"key":"1359_CR24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/mds.21409","volume":"22","author":"JJ Elm","year":"2007","unstructured":"Elm JJ, Kamp C, Tilley BC, Guimaraes P, Fraser D, Deppen P, Brocht A, Weaver C, Bennett S (2007) Self-reported adherence versus pill count in Parkinson\u2019s disease: the NET-PD experience. Mov Disord 22:822\u2013827","journal-title":"Mov Disord"},{"key":"1359_CR25","first-page":"59","volume":"15","author":"M Krousel-Wood","year":"2009","unstructured":"Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15:59\u201366","journal-title":"Am J Manag Care"},{"key":"1359_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377:127\u2013138","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1007\/s00277-017-3024-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T00:00:00Z","timestamp":1496966400000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1359-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1359-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1359-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:22Z","timestamp":1559037022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1359-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1359-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00277-017-3024-8","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}